Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Ezepeg** is a Mercury Laboratories gastrointestinal product brand rather than one uniquely defined active substance. It is marketed in at least two oral formulations: an Ezepeg powder containing polyethylene glycol 3350 for constipation, and a sugar-free orange-flavoured oral solution containing polyethylene glycol with sodium chloride, sodium bicarbonate, and potassium chloride for constipation relief and bowel cleansing before gastrointestinal procedures. Polyethylene glycol functions as an osmotic laxative by retaining water in the intestinal lumen, softening stool and promoting evacuation; the electrolyte-containing formulation is intended to help maintain fluid and electrolyte balance during bowel preparation. ([apollopharmacy.in](https://www.apollopharmacy.in/medicine/ezepeg-sugar-free-orange-flavour-oral-solution-200-ml))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ezepeg.